Celgene Corporation to Webcast at Upcoming Investor Conferences and Medical Meetings in May
April 23 2015 - 8:30AM
Business Wire
Celgene Corporation (NASDAQ:CELG) plans to present at three
upcoming investor conferences and two upcoming medical congresses
in May where Celgene management will provide an overview of the
Company. The conferences will be webcast live and a link to the
webcast will be available in the Investor Relations section of the
Company’s website at www.celgene.com.
Thursday, May 7, 2015, Celgene will present
at the Deutsche Bank 40th Annual Health Care Conference in Boston
at 9:20 am ET
Tuesday, May 12, 2015, Celgene will present
at the Bank of America Merrill Lynch 2015 Health Care Conference in
Las Vegas at 1:40 pm ET
Sunday, May 17, 2015, Celgene will present at
the Digestive Disease Week Annual Meeting in Washington, D.C. at
6:30 pm ET
Thursday, May 28, 2015 Celgene will present
at the Sanford C. Bernstein 31st Annual Strategic Decisions
Conference in New York at 3:00 pm ET
Sunday, May 31, 2015, Celgene will present at
the American Society of Clinical Oncology Annual Meeting in Chicago
at 7:30 pm ET
About Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in
the discovery, development and commercialization of innovative
therapies for the treatment of cancer and inflammatory diseases
through gene and protein regulation. For more information, please
visit www.celgene.com. Follow Celgene on Social Media: @Celgene,
Pinterest, LinkedIn and YouTube.
Forward-Looking Statements
This press release contains forward-looking statements, which
are generally statements that are not historical facts.
Forward-looking statements can be identified by the words
"expects," "anticipates," "believes," "intends," "estimates,"
"plans," "will," “outlook” and similar expressions. Forward-looking
statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are
made. We undertake no obligation to update any forward-looking
statement in light of new information or future events, except as
otherwise required by law. Forward-looking statements involve
inherent risks and uncertainties, most of which are difficult to
predict and are generally beyond our control. Actual results or
outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of
factors, many of which are discussed in more detail in our Annual
Report on Form 10-K and our other reports filed with the Securities
and Exchange Commission.
Celgene CorporationPatrick E. Flanigan III, 908-673-9969VP,
Investor RelationsorBrian Gill, 908-673-9530VP, Corporate
Communications
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Apr 2023 to Apr 2024